139 related articles for article (PubMed ID: 6786826)
1. Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; von der Ohe M; Nevinny-Stickel J
Contraception; 1981 Feb; 23(2):187-95. PubMed ID: 6786826
[TBL] [Abstract][Full Text] [Related]
2. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
Bergquist C; Nillius SJ; Wide L; Lindgren A
Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
[TBL] [Abstract][Full Text] [Related]
3. Ovulation inhibition by daily i.m. administration of a highly active LH-RH analog (d-ser(TBU)6-LH-RH-(1-9)-nonapeptide-ethylamide).
Baumann R; Kuhl H; Taubert HD; Sandow J
Contraception; 1980 Feb; 21(2):191-7. PubMed ID: 6768492
[TBL] [Abstract][Full Text] [Related]
4. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
6. Chronic treatment with a LH-RH-agonist: a new contraceptive method?
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J
Acta Eur Fertil; 1981 Sep; 12(3):275-6. PubMed ID: 6803498
[TBL] [Abstract][Full Text] [Related]
7. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
Kuhl H; Jung C; Taubert HD
Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
9. Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women.
Bergquist C; Nillius SJ; Wide L
Fertil Steril; 1982 Aug; 38(2):190-3. PubMed ID: 6809500
[TBL] [Abstract][Full Text] [Related]
10. [The influence of long-term medication with the LH-RH analogue buserelin on the regulation of the menstrual cycle (author's transl)].
Hardt W; Schmidt-Gollwitzer M; von der Ohe M; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1981 Nov; 41(11):791-6. PubMed ID: 6797869
[TBL] [Abstract][Full Text] [Related]
11. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
Skarin G; Nillius SJ; Wide L
Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women.
Lemay A; Faure N; Labrie F
Fertil Steril; 1982 Feb; 37(2):193-200. PubMed ID: 6800846
[TBL] [Abstract][Full Text] [Related]
14. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.
Lemay A; Maheux R; Faure N; Jean C; Fazekas AT
Fertil Steril; 1984 Jun; 41(6):863-71. PubMed ID: 6427019
[TBL] [Abstract][Full Text] [Related]
15. Chronic effects of the stimulatory luteinizing hormone-releasing hormone analogue D-Ser (TBU) 6-EA 10-LRH on the gonadotrophin and gonadal steroid secretion in women with amenorrhoea.
Skarin G; Nillius SJ; Wide L
Ups J Med Sci; 1980; 85(2):103-12. PubMed ID: 6787767
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue - a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-44. PubMed ID: 363344
[TBL] [Abstract][Full Text] [Related]
17. Effects of buserelin injection and deslorelin (GnRH-agonist) implants on plasma progesterone, LH, accessory CL formation, follicle and corpus luteum dynamics in Holstein cows.
Rajamahendran R; Ambrose JD; Schmitt EJ; Thatcher MJ; Thatcher WW
Theriogenology; 1998 Nov; 50(7):1141-55. PubMed ID: 10734431
[TBL] [Abstract][Full Text] [Related]
18. Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent.
Bergquist C; Nillius SJ; Wide L
Lancet; 1979 Aug; 2(8136):215-7. PubMed ID: 89330
[TBL] [Abstract][Full Text] [Related]
19. Gonadotrophin-releasing hormone treatment for induction of follicular maturation and ovulation in amenorrhoeic women with anorexia nervosa.
Nillius SJ; Wide L
Br Med J; 1975 Aug; 3(5980):405-8. PubMed ID: 1098720
[TBL] [Abstract][Full Text] [Related]
20. Effects of prolonged luteinizing hormone-releasing hormone therapy on follicular maturation, ovulation and corpus luteum function in amenorrhoeic women with anorexia nervosa.
Nillius SJ; Wide L
Ups J Med Sci; 1979; 84(1):21-35. PubMed ID: 375526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]